Please try another search
For the six months ended 30 June 2016, Sequenom, Inc. revenues decreased 19% to $56.9M. Net loss totaled $19.8M vs. income of $5.3M. Revenues reflect Diagnostic services, net decrease of 22% to $51.9M. Net loss reflects Gain on pooled patents agreement decrease from $21M (income) to $0K, Selling and marketing increase of 1% to $16.9M (expense), Interest expense increase of 1% to $4M (expense).
Period Ending: | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
---|---|---|---|---|
Total Revenue | 29.29 | 27.57 | 27.81 | 29.9 |
Gross Profit | 15.53 | 10.77 | 11.83 | 14.83 |
Operating Income | -4.46 | -11.36 | -10.06 | -7.28 |
Net Income | -6.31 | -13.45 | -12.16 | -9.44 |
Period Ending: | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
---|---|---|---|---|
Total Assets | 97.33 | 104.62 | 116.73 | 128.71 |
Total Liabilities | 151.81 | 154.54 | 155.13 | 156.41 |
Total Equity | -54.48 | -49.93 | -38.4 | -27.71 |
Period Ending: | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -15.14 | -10.07 | -20.2 | -16.02 |
Cash From Investing Activities | 25.6 | 4.84 | 10.49 | 5.41 |
Cash From Financing Activities | -0.07 | 0.14 | -3.21 | -3 |
Net Change in Cash | 10.39 | -5.09 | -12.96 | -13.64 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review